rna
virus
possess
highest
mutat
rate
natur
calcul
drake
et
al
drake
holland
even
compar
modest
retrovirus
gener
mutat
per
genom
per
replic
cycl
lead
enorm
variat
viral
progeni
rna
viru
mutat
rate
therefor
magnitud
higher
dna
organ
escherichia
coli
saccharomyc
cerevisia
larg
part
due
lack
proofread
mechan
rnadepend
rna
polymeras
rdrp
mutat
rate
fix
given
organ
high
lowfidel
variant
e
coli
yeast
alreadi
describ
earli
fluri
et
al
gillin
nossal
three
princip
mechan
contribut
fidel
e
coli
intrins
polymeras
fidel
mani
correct
versu
incorrect
nucleotid
incorpor
exonucleas
proofread
activ
dna
mismatch
repair
schaaper
mechan
alter
obtain
variant
alter
replic
fidel
interestingli
work
e
coli
also
suggest
mutat
rate
given
organ
fix
dynam
instanc
least
one
percent
natur
isol
mutat
variant
jyssum
gross
siegel
leclerc
et
al
remark
passag
e
coli
gener
limit
glucos
environ
sniegowski
et
al
show
bacteri
popul
develop
mutat
rate
one
twofold
higher
wild
type
suggest
fluctuat
environ
mutat
allel
potenti
benefici
taddei
et
al
follow
work
bacteria
studi
bacteriophag
herp
simplex
viru
demonstr
observ
could
extend
dna
virus
muzyczka
et
al
hall
et
al
case
strain
miss
essenti
proofread
function
case
point
mutat
polymeras
led
alter
correct
nucleotid
incorpor
rate
muzyczka
et
al
rehakrantz
et
al
retrovirus
base
analogresist
hiv
strain
report
revers
transcriptas
mutat
eg
alter
fidel
rnadepend
dna
polymeras
howev
measur
fidel
strain
controversi
clearli
establish
recent
wainberg
et
al
bakhanashvili
et
al
dapp
et
al
keulen
et
al
manski
et
al
recent
discoveri
intrins
rdrp
fidel
alter
allow
research
examin
restrict
highfidelityantimut
expand
lowfidelitymut
viral
popul
divers
impact
viral
pathogenesi
adapt
evolut
first
bona
fide
highfidel
variant
rna
viru
isol
independ
two
laboratori
pfeiffer
kirkegaard
vignuzzi
et
al
serial
passag
polioviru
presenc
ribavirin
select
resist
variant
incorpor
ribavirin
directli
nascent
genom
polioviru
replic
result
transit
mutat
princip
g
g
c
u
detriment
effect
viru
sequenc
polymeras
gene
ribavirinresist
popul
reveal
one
amino
acid
chang
hypothes
resist
due
activ
polymeras
simpli
gener
progeni
genom
permit
better
surviv
b
polymeras
longer
recogn
ribavirin
base
analog
c
overal
increas
polymeras
fidel
select
correct
nucleotid
sever
observ
support
last
mechan
exhibit
replic
wildtyp
viru
singlecycl
infect
gener
fewer
escap
mutant
antivir
compound
also
resist
base
analog
differ
structur
pfeiffer
kirkegaard
vignuzzi
et
al
parallel
biochem
studi
confirm
highfidel
enzym
directli
demonstr
rate
incorrect
nucleotid
incorpor
fourfold
lower
wild
type
arnold
et
al
direct
sequenc
genom
reveal
mutat
frequenc
sixfold
lower
popul
vignuzzi
et
al
addit
introduc
amino
acid
v
l
posit
also
gener
highfidel
variant
vignuzzi
et
al
follow
studi
polioviru
perform
passag
mutagen
gener
resist
variant
becam
gener
strategi
isol
highfidelityantimut
variant
beaucourt
et
al
coxsacki
viru
also
picornavirida
famili
treat
moder
concentr
ribavirin
anoth
rna
mutagen
within
passag
new
mutat
aros
rdrp
mutat
alon
confer
resist
effect
three
rna
mutagen
high
concentr
increas
fidel
confirm
sequenc
biochem
assay
levi
et
al
guid
highfidel
polioviru
studi
sadeghipour
et
al
identifi
ribavirinresist
variant
human
enteroviru
although
alter
growth
kinet
make
result
difficult
interpret
least
one
variant
bona
fide
antimut
addit
serial
passag
ribavirin
led
anoth
mutat
rdrp
confer
resist
increas
fidel
sadeghipour
et
al
recent
anoth
group
found
mutat
rdrp
increas
fidel
meng
kwang
final
highfidel
polymeras
variant
found
footandmouth
diseas
viru
fmdv
also
picornavirida
famili
select
serial
passag
rna
mutagen
resist
phenotyp
correl
appear
mutat
rdrp
mutat
also
confer
crossresist
ribavirin
mutat
frequenc
significantli
lower
wildtyp
viru
zeng
et
al
group
later
isol
quadrupl
polymeras
mutant
damm
exhibit
twofold
decreas
replic
error
yet
crossresist
mutagen
zeng
et
al
rais
question
whether
damm
truli
highfidel
recent
number
highfidel
rdrp
variant
describ
outsid
picornaviru
famili
highfidel
chikungunya
viru
obtain
serial
passag
ribavirin
coffey
et
al
picornaviru
highfidel
variant
variant
resist
multipl
rna
mutagen
gener
popul
restrict
genet
divers
wildtyp
viru
mutagenresist
influenza
viru
variant
also
shown
increas
fidel
cheung
et
al
two
mutat
west
nile
viru
rdrp
also
shown
confer
mutagen
resist
fidel
increas
van
slyke
et
al
thu
mutagen
resist
proven
use
strategi
isol
variant
highfidel
polymeras
first
rdrp
variant
confirm
lower
fidel
fmdv
mutant
unexpectedli
isol
screen
resist
ribavirin
interestingli
mutant
spectrum
gener
variant
contain
bia
toward
transit
mutat
expect
exposur
ribavirin
complex
mutant
spectrum
similar
wildtyp
viru
absenc
ribavirin
sierra
et
al
passag
ribavirin
result
select
tripl
mutant
resist
ribavirin
without
acquir
resist
mutagen
agudo
et
al
collect
data
support
hypothesi
variant
specif
resist
ribavirin
incorpor
rna
synthesi
inde
biochem
studi
show
polymeras
incorpor
twofold
less
rtp
wildtyp
enzym
gener
twofold
g
transit
explain
lack
mutagenesi
presenc
ribavirin
well
lack
lower
mutant
frequenc
although
inform
fmdv
variant
appear
except
rule
gener
one
would
expect
mutagen
sensit
rather
resist
hallmark
low
fidel
howev
select
mutagensensit
variant
challeng
gener
lowfidel
variant
one
case
influenza
virus
mutat
phenotyp
isol
select
escap
variant
singl
plaqu
transfer
sequenti
treatment
monoclon
antibodi
et
al
work
preced
studi
rdrp
fidel
decad
go
confirm
whether
mutat
statu
map
polymeras
gene
part
lowfidel
rdrp
variant
identifi
perform
sitedirect
mutagenesi
target
residu
near
catalyt
site
approach
proven
success
hiv
polioviru
polymeras
martinhernandez
et
al
korneeva
cameron
addit
polioviru
fidel
lower
introduc
amino
acid
chang
near
catalyt
site
polioviru
rdrp
liu
et
al
initi
studi
mutagen
coxsacki
viru
uncov
lowfidel
rdrp
variant
levi
et
al
recent
studi
target
residu
coxsacki
viru
base
implic
close
relat
polioviru
fidel
network
predict
polymeras
structur
catalysi
arnold
et
al
gong
peersen
nine
lower
fidel
variant
isol
present
elev
mutat
frequenc
et
al
fig
fmdv
lowfidel
variant
recent
shown
increas
mutat
frequenc
render
variant
suscept
mutagenesi
xie
et
al
order
obtain
lowfidel
variant
chikungunya
viru
possibl
amino
acid
swap
polymeras
posit
previous
shown
result
highfidel
enzym
rozengagnon
et
al
fig
three
variant
prove
lowfidel
sinc
cystein
posit
highli
conserv
among
alphavirus
similar
mutat
sindbi
viru
analog
posit
also
gener
two
mutat
west
nile
viru
mutat
methyl
transferas
domain
protein
shown
decreas
replic
fidel
like
interact
rdrp
van
slyke
et
al
final
eckerl
colleagu
mutagen
activ
site
need
coronaviru
exonucleas
activ
ablat
coronaviru
cov
proofread
activ
result
murin
hepat
viru
mhvcov
eckerl
et
al
sever
acut
respiratori
syndrom
sarscov
eckerl
et
al
increas
mutat
frequenc
major
viral
fidel
variant
identifi
significantli
attenu
vivo
consequ
fidel
variant
rare
observ
natur
isol
howev
phenotyp
genotyp
assay
use
discrimin
fidel
chang
may
sensit
enough
detect
subtl
differ
among
natur
isol
furthermor
given
quasispeci
natur
rna
viru
popul
known
whether
fidel
variant
exist
low
frequenc
within
mutant
spectrum
whether
would
modul
overal
popul
fidel
instanc
coxsacki
viru
mutat
strain
present
mutat
frequenc
nearer
wildtyp
valu
display
attenu
phenotyp
et
al
rais
possibl
slightli
elev
mutat
rate
could
advantag
condit
requir
rapid
adapt
interestingli
coxsacki
viru
variant
respect
present
moder
higher
lower
fidel
exist
natur
isol
threonin
posit
found
isol
valin
posit
found
harrison
et
al
thu
possibl
given
time
rna
viru
quasispeci
contain
subpopul
mutat
antimut
whose
frequenc
may
fluctuat
environment
pressur
requir
rapid
evolut
better
mainten
genet
integr
importantli
studi
fidel
variant
tissu
cultur
nearli
exclus
perform
highli
permiss
immort
cell
line
replic
cycl
recent
studi
show
mutat
rate
frequenc
virus
dramat
chang
depend
cell
type
rozengagnon
et
al
comb
sanjuan
therefor
stringent
select
pressur
fidel
rna
virus
may
adjust
inde
evolut
mutat
rate
observ
bacteria
colon
vivo
condit
starvat
sniegowski
et
al
similar
phenomenon
may
occur
rna
virus
remain
demonstr
errorpron
viral
rdrp
primari
sourc
divers
observ
rna
viru
popul
inde
rna
viru
fidel
variant
isol
contain
mutat
rdrp
except
thu
far
mutat
coronavirus
lack
exonucleas
activ
eckerl
et
al
rdrp
structur
conserv
across
viru
famili
rdrp
structur
solv
member
flavivirida
includ
hepat
c
viru
bovin
viral
diarrhea
viru
japanes
enceph
viru
west
nile
viru
dengu
viru
lu
gong
yap
et
al
malet
et
al
choi
et
al
bressanelli
et
al
lesburg
et
al
calciviridai
includ
rabbit
hemorrhag
diseas
viru
norwalk
viru
sapoviru
reoviru
bacteriophag
ng
et
al
fullerton
et
al
butcher
et
al
salgado
et
al
tao
et
al
picornavirida
includ
coxsacki
viru
polioviru
fmdv
human
rhinoviru
encephalomyocard
viru
chen
et
al
gruez
et
al
love
et
al
ferrerorta
applebi
et
al
thompson
peersen
hansen
et
al
vivesadrian
et
al
birnavirida
includ
infecti
bursal
diseas
viru
pan
et
al
orthomyxovirida
includ
influenza
viru
et
al
polymeras
righthand
architectur
compris
finger
palm
thumb
domain
rdrp
exist
close
hand
format
accomplish
connect
finger
thumb
domain
review
see
ferrerorta
et
al
ng
et
al
loop
extend
finger
fingertip
surround
activ
site
creat
entranc
templat
channel
templat
recognit
occur
butcher
et
al
ferrerorta
farrel
et
al
templat
channel
connect
finger
activ
site
locat
palm
palm
made
threestrand
highli
conserv
featur
catalyt
domain
contain
conserv
motif
present
rdrp
thu
far
catalyz
nucleotidyl
transfer
reaction
enzymat
function
reli
twometalion
mechan
propos
polymeras
mechan
first
shown
rdrp
use
polioviru
rdrp
ng
et
al
steitz
arnold
et
al
incom
nucleotid
enter
activ
site
metal
ion
b
orient
ntp
activ
site
use
ntp
conserv
aspart
acid
asp
motif
follow
metal
ion
bind
group
ntp
asp
motif
anoth
conserv
asp
motif
c
addit
metal
ion
bind
nascent
rna
strand
lower
affin
h
allow
nucleophil
attach
ntp
ng
et
al
steitz
therefor
two
proton
transfer
reaction
castro
et
al
one
nascent
rna
unknown
acceptor
one
pyrophosph
ppi
leav
group
gener
acid
usual
lysin
motif
castro
et
al
cameron
et
al
presenc
gener
acid
greatli
enhanc
effici
catalysi
castro
et
al
fig
b
structur
wildtyp
rdrp
fidel
variant
essenti
ident
one
amino
acid
chang
indic
structur
dynam
nucleotid
addit
like
alter
fidel
largescal
structur
chang
cameron
et
al
marcott
et
al
isol
highfidel
variant
design
novel
substrat
biochem
studi
uncov
mechan
nucleotid
addit
novel
symmetr
substrat
call
symsub
selfcomplementari
heteropolymer
rna
primer
regardless
orient
enzym
bind
permit
extens
substrat
arnold
cameron
use
symsub
five
kinet
step
observ
incorpor
singl
nucleotid
nascent
rna
call
singlenucleotid
addit
cycl
cycl
like
conserv
rdrp
begin
ntp
bind
enzymetempl
complex
ernntp
follow
conform
chang
allow
complex
becom
catalyt
activ
ernntp
phosphodiest
bond
form
incom
nucleotid
nascent
strand
lead
second
conform
chang
follow
pyrophosph
releas
arnold
cameron
arnold
et
al
fig
shown
step
first
conform
chang
phosphoryl
transfer
partial
ratelimit
singlenucleotid
addit
cycl
therefor
like
influenc
fidel
step
involv
reorient
triphosph
ntp
avail
phosphoryl
transfer
interact
residu
ribosebind
pocket
interact
alter
incorrect
bound
nucleotid
reduc
stabil
complex
bound
nucleotid
rate
follow
phosphoryl
transfer
arnold
cameron
arnold
et
al
gohara
et
al
therefor
residu
bind
pocket
crucial
determin
correct
nucleotid
present
gohara
et
al
inde
sever
conserv
residu
play
major
role
orient
stabil
incom
ntp
gohara
et
al
triphosph
properli
orient
stabil
hydrogen
bond
network
within
residu
bind
pocket
mostli
locat
motif
addit
motif
interact
motif
b
interact
oh
tightli
hold
incom
triphosph
proper
orient
also
shown
crucial
ntp
orient
fmdv
rdrp
ferrerorta
et
al
furthermor
motif
conserv
anim
viru
rdrp
koonin
base
work
propos
bind
pocket
divid
univers
portion
motif
adapt
portion
motif
b
motif
intersect
nucleotidebind
pocket
motif
carri
univers
enzymat
function
motif
b
involv
nucleotid
select
motif
residu
presum
link
rate
phosphoryl
transfer
select
nucleotid
reduc
transfer
effici
incorrect
nucleotid
bound
gohara
et
al
hydrogen
bond
network
interact
triphosph
specif
bind
pocket
residu
determin
stabil
activ
complex
rate
follow
phosphoryl
transfer
recent
work
also
link
motif
effici
fidel
newli
incorpor
nucleotid
conserv
lysin
polioviru
shown
act
gener
acid
proton
ppi
castro
et
al
new
result
indic
motif
lysin
might
interact
ntp
achiev
activ
close
enzym
conform
furthermor
bind
incorrect
ntp
shift
rdrp
conform
away
activ
state
motif
lysin
must
proton
order
achiev
rdrp
activ
state
yang
et
al
may
explain
polioviru
mutant
motif
alter
fidel
phenotyp
liu
et
al
castro
et
al
yang
et
al
dynam
chang
motif
shown
nuclear
magnet
reson
cameron
et
al
previous
mask
crystal
structur
rdrp
elong
complex
gong
peersen
ferrerorta
et
al
although
residu
remot
activ
site
finger
domain
polymeras
shown
lower
equilibrium
constant
conform
chang
orient
stabil
incom
ntp
step
fact
residu
indirectli
connect
motif
via
hydrogen
bond
substitut
posit
ablat
hydrogen
bond
explain
reduc
equilibrium
constant
step
arnold
et
al
although
unclear
could
connect
motif
conform
chang
found
occur
motif
incorrect
nucleotid
bound
occur
wildtyp
polymeras
decreas
abil
switch
catalyt
activ
form
incorrect
nucleotid
bound
lead
higher
fidel
polymeras
arnold
et
al
yang
et
al
similar
mechan
shown
involv
equival
mutat
fmdv
ferrerorta
et
al
somewhat
difficult
make
gener
biochem
experi
examin
fidel
avail
polioviru
fmdv
coxsacki
viru
although
except
aria
et
al
seem
higher
fidel
polymeras
tend
kinet
slower
lowfidel
polymeras
tend
faster
notabl
shown
case
highfidel
polioviru
fmdv
arnold
et
al
yang
et
al
ferrerorta
et
al
lowfidel
polioviru
strain
liu
et
al
et
al
kinet
proofread
hypothesi
predict
like
tradeoff
fast
faith
replic
coffey
et
al
hopfield
without
proofread
mechan
case
major
rna
virus
increas
accuraci
may
achiev
reduc
rate
polymer
allow
decreas
stabil
incorrect
nucleotid
higher
dissoci
constant
result
prefer
correct
nucleotid
phenomenon
well
support
structur
biochem
studi
polioviru
arnold
et
al
castro
et
al
yang
et
al
also
shown
biochem
fidel
assay
correl
well
vitro
tissu
cultur
measur
mutat
frequenc
et
al
howev
discrep
rel
rate
nucleotid
incorpor
biochem
assay
use
rdrp
enzym
versu
overal
viru
growth
tissu
cultur
exampl
even
though
biochem
data
suggest
polioviru
reduc
yield
assembl
elong
complex
grew
ident
wild
type
onestep
growth
curv
necessarili
surpris
given
singlenucleotid
incorpor
cycl
cellfre
solut
equival
complet
viral
life
cycl
within
infect
cell
includ
bind
entri
replic
packag
egress
interestingli
grow
competit
wild
type
reveal
reduc
rel
fit
arnold
et
al
vitro
growth
pattern
sinc
develop
recur
trend
rdrp
fidel
variant
high
low
grow
similarli
wild
type
isol
competit
wild
type
suffer
replic
fit
cost
zeng
et
al
coffey
et
al
et
al
et
al
levi
et
al
studi
revers
transcriptas
antimut
show
mutat
frequenc
wild
type
lower
rel
fit
competit
assay
dapp
et
al
et
al
import
except
gener
rule
mhv
sar
coronaviru
mutat
lack
exonucleas
activ
variant
exhibit
clear
stabl
defect
one
log
replic
compar
wild
type
eckerl
et
al
graham
et
al
fidel
variant
gener
fewer
mutat
wildtyp
virus
without
present
alter
consensu
sequenc
respect
parent
strain
therefor
proven
invalu
tool
address
role
mutant
spectrum
viru
fit
behavior
quasispeci
vivo
although
major
growth
defect
gener
observ
vitro
vivo
attenu
seem
gener
rule
fidel
variant
fig
preced
vivo
attenu
set
polioviru
highfidel
variant
pfeiffer
kirkegaard
demonstr
less
pathogen
wildtyp
viru
mice
despit
find
signific
replic
differ
vitro
vignuzzi
et
al
also
demonstr
attenu
phenotyp
lethal
dose
mice
higher
wild
type
furthermor
viru
popul
could
colon
infect
spleen
kidney
muscl
intestin
system
inocul
perform
unabl
dissemin
distal
infect
cn
shed
fece
sequenc
individu
genom
highfidel
popul
vivo
confirm
restrict
genet
divers
studi
restrict
quasispeci
artifici
expand
mutagen
treatment
present
number
mutat
wild
type
importantli
expand
popul
recov
abil
infect
colon
spinal
cord
brain
similar
lethal
dose
compar
wild
type
furthermor
coinfect
restrict
popul
either
wild
type
allow
genet
restrict
popul
invad
spinal
cord
brain
semin
work
provid
strong
evid
consensu
chang
impact
virul
pathogenesi
mutant
spectrum
complex
also
critic
pathogenesi
andor
viru
surviv
vivo
although
alway
case
studi
also
provid
indirect
evid
cooper
interact
within
quasispeci
may
play
role
viru
infect
diseas
progress
sinc
first
report
alter
mutat
frequenc
link
attenu
anim
model
sever
variant
recent
studi
fmdv
also
demonstr
higher
fidel
greater
attenu
newborn
mous
model
zeng
et
al
higher
fidel
variant
alon
combin
attenu
mice
sadeghipour
mcminn
recent
anoth
antimut
also
exhibit
reduc
virul
delay
symptom
mous
model
meng
kwang
final
chikungunya
viru
highfidel
variant
quickli
clear
newborn
mous
model
moder
attenu
mosquito
coffey
et
al
signific
attenu
also
observ
colon
field
mosquito
infect
west
nile
viru
highfidel
variant
van
slyke
et
al
highfidel
influenza
viru
replic
wildtypelik
titer
lung
infect
mice
lethal
neurotrop
reduc
tenfold
cheung
et
al
similar
trend
observ
lowfidelitymut
variant
mice
inocul
sarscov
strain
lack
exonucleas
activ
exon
exhibit
reduc
symptom
rapid
clearanc
viru
lung
furthermor
exon
mutant
retain
elev
mutat
frequenc
vivo
graham
et
al
coxsacki
viru
mutat
strain
exhibit
reduc
titer
sever
target
organ
mous
model
unabl
establish
persist
infect
gener
degre
attenu
correl
extrem
mutat
phenotyp
et
al
recent
studi
demonstr
higher
surviv
mice
inocul
lowfidel
polioviru
liu
et
al
alphavirus
lowfidel
variant
chikungunya
viru
show
reduc
titer
tissu
test
mice
includ
primari
target
tissu
muscl
similarli
sindbi
viru
mutat
attenu
mice
present
fewer
neurolog
symptom
limb
paralysi
also
attenu
fruit
fli
model
drosophila
melanogast
rozengagnon
et
al
fig
lowfidel
methyl
transferas
variant
west
nile
viru
also
shown
compromis
mosquito
host
van
slyke
et
al
except
rule
exist
fmdv
highfidel
present
increas
mutat
frequenc
result
attenu
mice
zeng
et
al
possibl
explan
lack
mutat
variant
manifest
moder
differ
mutat
frequenc
twofold
compar
attenu
variant
describ
fmdv
therefor
may
threshold
mutat
frequenc
attenu
observ
support
threshold
recent
studi
demonstr
rang
lowfidel
fmdv
rdrp
variant
extrem
mutat
attenu
vivo
present
twofold
increas
mutat
frequenc
retain
virul
xie
et
al
similar
data
found
coxsacki
viru
et
al
mutat
highest
mutat
frequenc
attenu
consequ
threshold
differ
depend
viru
abil
cope
increas
mutat
load
graci
et
al
base
nearli
univers
attenu
fidel
variant
vivo
strain
explor
live
attenu
vaccin
lav
group
use
fidel
variant
elicit
protect
studi
promis
first
studi
examin
immunogen
protect
origin
highfidel
polioviru
well
highfidel
strain
mice
author
observ
reduc
viral
shed
high
neutral
antibodi
titer
inde
higher
induc
inocul
sabin
vaccin
strain
importantli
immun
confer
longterm
protect
month
singl
immun
fidel
variant
major
mice
surviv
lethal
challeng
wildtyp
polioviru
vignuzzi
et
al
second
studi
evalu
sarscov
exon
mutat
vaccin
candid
show
mutat
remain
attenu
even
immunocompromis
age
mice
group
concern
routin
immun
addit
immun
mutat
strain
elicit
antibodi
respons
confer
resist
lethal
challeng
viru
detect
lung
immun
mice
graham
et
al
lav
proven
efficaci
subunit
vaccin
counterpart
pose
safeti
concern
review
see
laur
et
al
one
princip
concern
lav
revers
virul
observ
number
lav
includ
sabin
strain
polioviru
cann
et
al
mutat
strain
rais
question
safeti
stabil
lav
gener
mutat
wildtyp
virus
sarscov
exon
mutat
shown
remain
stabl
mous
model
likewis
exon
mutat
allow
establish
persist
infect
scid
mice
day
revers
detect
inactiv
exonucleas
site
interestingli
one
attenu
mutat
present
rdrp
sabin
strain
polioviru
shown
decreas
fidel
rais
possibl
current
use
vaccin
attenu
alreadi
achiev
part
alter
natur
fidel
rna
viru
although
whether
strain
includ
attenu
mutat
retain
lower
fidel
shown
liu
et
al
addit
highfidel
poliovirus
passag
mice
revert
posit
remain
attenu
lav
develop
highfidel
variant
may
particular
interest
sinc
lower
mutat
frequenc
make
mutat
confer
virul
less
like
occur
inde
select
pressur
revert
vivo
highfidel
variant
less
abl
wherea
wildtyp
viru
quickli
revert
significantli
higher
number
site
vignuzzi
et
al
sinc
fidelityalt
mutat
map
singl
residu
combin
convent
attenu
mutat
may
good
strategi
reduc
revers
virul
virus
appear
finetun
mutat
rate
order
maxim
adapt
time
maintain
genom
integr
deviat
optim
mutat
rate
shown
attenu
propos
explan
observ
attenu
mutat
meltdown
lose
abil
maintain
genet
inform
due
extrins
increas
mutat
rate
eigen
domingo
et
al
importantli
consequ
studi
lethal
mutagenesi
antivir
approach
discoveri
highfidel
variant
gener
resist
mutationinduc
drug
discoveri
boost
interest
determin
viral
mutat
rate
could
modul
intrins
lead
isol
fidel
variant
larg
panel
high
lowfidel
variant
avail
feedback
research
lethal
mutagenesi
antivir
approach
due
alter
sensit
compound
excel
tool
investig
mutagen
activ
known
compound
identifi
new
mutagen
compound
inde
first
high
lowfidel
variant
coxsacki
viru
key
identifi
previous
unknown
mutagen
activ
amilorid
compound
levi
et
al
similar
screen
use
compound
librari
may
thu
identifi
class
antivir
mutagen
effect
tabl
